Ignite Creation Date:
2024-05-06 @ 12:38 AM
Last Modification Date:
2024-10-26 @ 10:52 AM
Study NCT ID:
NCT01625234
Status:
COMPLETED
Last Update Posted:
2021-10-06
First Post:
2012-06-15
Brief Title:
Phase 12 Study of X-396 an Oral ALK Inhibitor in Patients With ALK-positive Non-Small Cell Lung Cancer
Sponsor:
Xcovery Holdings Inc
Organization:
Xcovery Holdings Inc
Organization Data
Organization:
Xcovery Holdings Inc
Class:
INDUSTRY
Study ID:
X396-CLI-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xcovery Holdings Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None